1998
DOI: 10.1128/jvi.72.3.2505-2508.1998
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Mapping of the Cloned Subgroup A Avian Sarcoma and Leukosis Virus Receptor Gene to the TVA Locus

Abstract: A chicken gene conferring susceptibility to subgroup A avian sarcoma and leukosis viruses (ASLV-A) was recently identified by a gene transfer strategy. Classical genetic approaches had previously identified a locus, TVA, that controls susceptibility to ASLV-A. Using restriction fragment length polymorphism (RFLP) mapping in inbred susceptible (TVA*S) and resistant (TVA*R) chicken lines, we demonstrate that in 93 F2 progeny an RFLP for the cloned receptor gene segregates with TVA. From these analyses we calcula… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
8
0

Year Published

1999
1999
2019
2019

Publication Types

Select...
6
2
2

Relationship

1
9

Authors

Journals

citations
Cited by 39 publications
(8 citation statements)
references
References 18 publications
(21 reference statements)
0
8
0
Order By: Relevance
“…We then analysed the ability of the TRIM proteins to interfere with viral entry defined here as all early events in the retroviral life cycle leading up to the establishment of viral gene expression ( Figure 1 A). To identify activities directed specifically against incoming retroviral capsids, all viruses carried the same subgroup A envelope glycoprotein of ALV (ALV-A) and target cells expressed the cognate receptor Tva950 [ 29 ]. To guarantee a ∼90% probability of Tva950 co-expression with each TRIM protein, plasmids encoding for both proteins were co-transfected 36 h prior to initiating infection.…”
Section: Resultsmentioning
confidence: 99%
“…We then analysed the ability of the TRIM proteins to interfere with viral entry defined here as all early events in the retroviral life cycle leading up to the establishment of viral gene expression ( Figure 1 A). To identify activities directed specifically against incoming retroviral capsids, all viruses carried the same subgroup A envelope glycoprotein of ALV (ALV-A) and target cells expressed the cognate receptor Tva950 [ 29 ]. To guarantee a ∼90% probability of Tva950 co-expression with each TRIM protein, plasmids encoding for both proteins were co-transfected 36 h prior to initiating infection.…”
Section: Resultsmentioning
confidence: 99%
“…Several cell surface proteins have been identified as ALV receptors. Tva, the receptor for ALV(A), contains sequences related to the ligand binding region of low-density lipoprotein receptors (LDLR) (7,8,69). TvbS3, a receptor for ALV(B) and ALV(D) (13,60), TvbT, a receptor for ALV(E) (1), and TvbS1, a receptor for ALV(B), ALV(D), and ALV(E) (2), are all members of the tumor necrosis factor receptor family.…”
mentioning
confidence: 99%
“…Tva was the first ASLV receptor identified (7,72) and has been mapped to the TVA locus (6). While it has been shown to function as a viral receptor, the cellular function of Tva remains unknown.…”
mentioning
confidence: 99%